1
项与 CD19 UCAR-T (Suzhou Maximum Bio-tech) 相关的临床试验To evaluate the safety and tolerability of CD19 UCAR-T cell injection in subjects with recurrent/refractory CD19 positive B cell malignancies
100 项与 CD19 UCAR-T (Suzhou Maximum Bio-tech) 相关的临床结果
100 项与 CD19 UCAR-T (Suzhou Maximum Bio-tech) 相关的转化医学
100 项与 CD19 UCAR-T (Suzhou Maximum Bio-tech) 相关的专利(医药)
100 项与 CD19 UCAR-T (Suzhou Maximum Bio-tech) 相关的药物交易